KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $93.2 million.

  • Idexx Laboratories' Deferred Taxes rose 146148.34% to $93.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $104.4 million, marking a year-over-year increase of 26715.68%. This contributed to the annual value of -$24.2 million for FY2024, which is 4991.51% up from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Deferred Taxes is $93.2 million, which was up 146148.34% from $2.5 million recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Deferred Taxes peaked at $93.2 million during Q3 2025, and registered a low of -$33.6 million during Q4 2023.
  • Moreover, its 5-year median value for Deferred Taxes was -$2.6 million (2024), whereas its average is -$593000.0.
  • Per our database at Business Quant, Idexx Laboratories' Deferred Taxes crashed by 918680.56% in 2022 and then soared by 146148.34% in 2025.
  • Over the past 5 years, Idexx Laboratories' Deferred Taxes (Quarter) stood at -$7.4 million in 2021, then surged by 124.58% to $1.8 million in 2022, then tumbled by 1938.74% to -$33.6 million in 2023, then skyrocketed by 113.93% to $4.7 million in 2024, then soared by 1894.18% to $93.2 million in 2025.
  • Its Deferred Taxes was $93.2 million in Q3 2025, compared to $2.5 million in Q2 2025 and $3.9 million in Q1 2025.